Join
Live feed
·
PRReleasevia Quantisnow
Jade Biosciences Inc. logo

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025

ByQuantisnow·Wall Street's wire, on your screen.
JBIO· Jade Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JBIO (Jade Biosciences Inc.) and more on Quantisnow.